Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

March 2012 - FRMC

Combination of Investigational Drugs Helps Alleviate Hepatitis C Symptoms
03/16/2012

Eileen Koutnik-Fotopoulos

Eileen Koutnik-Fotopoulos
The results from a small study of patients with hepatitis C virus (HCV) genotype 1 infection showed that a combination of 2 investigational drugs suppressed the virus for patients who previously had no response to treatment. The findings are...
The results from a small study of patients with hepatitis C virus (HCV) genotype 1 infection showed that a combination of 2 investigational drugs suppressed the virus for patients who previously had no response to treatment. The findings are...
The results from a small study...
03/16/2012
First Report Managed Care
Antigen Therapy for Type 1 Diabetes
03/16/2012

Kevin L. Carter

Kevin L. Carter
The onset of type 1 diabetes is manifested by the effects of inadequate insulin secretion due to the immunologic destruction of pancreatic-islet beta-cells. Even modest preservation of insulin secretion appears to reduce short- and long-term...
The onset of type 1 diabetes is manifested by the effects of inadequate insulin secretion due to the immunologic destruction of pancreatic-islet beta-cells. Even modest preservation of insulin secretion appears to reduce short- and long-term...
The onset of type 1 diabetes is...
03/16/2012
First Report Managed Care
Neoadjuvant Chemotherapy and Bevacizumab for HER2-Negative Breast Cancer
03/16/2012

Kevin L. Carter

Kevin L. Carter
When neoadjuvant chemotherapy agents (anthracyclines, taxanes, and agents directed against antihuman epidermal growth factor receptor 2 [HER2], if indicated), are used, approximately 30% to 40% of all breast cancers that are HER2-positive or...
When neoadjuvant chemotherapy agents (anthracyclines, taxanes, and agents directed against antihuman epidermal growth factor receptor 2 [HER2], if indicated), are used, approximately 30% to 40% of all breast cancers that are HER2-positive or...
When neoadjuvant chemotherapy...
03/16/2012
First Report Managed Care
Increased Risk of Falls, Fractures and Narcotics
03/16/2012

Mary Beth Nierengarten

Mary Beth Nierengarten
Chicago—Current guidelines that recommend short-term narcotic analgesics (NAs) as first-line treatment for managing chronic pain may need to be reevaluated based on new data that show an increased risk of falls and fractures in elderly...
Chicago—Current guidelines that recommend short-term narcotic analgesics (NAs) as first-line treatment for managing chronic pain may need to be reevaluated based on new data that show an increased risk of falls and fractures in elderly...
Chicago—Current guidelines that...
03/16/2012
First Report Managed Care
Cardiovascular Risk in Patients with Rheumatoid Arthritis
03/16/2012

Mary Beth Nierengarten

Mary Beth Nierengarten
Chicago—In patients with rheumatoid arthritis (RA), the length of disease duration does not appear to aggravate or contribute to cardiovascular risk, but very low disease activity sustained over time may actually have a beneficial effect on...
Chicago—In patients with rheumatoid arthritis (RA), the length of disease duration does not appear to aggravate or contribute to cardiovascular risk, but very low disease activity sustained over time may actually have a beneficial effect on...
Chicago—In patients with...
03/16/2012
First Report Managed Care
Long-Term Treatment for Fibromyalgia with Milnacipran
03/16/2012

Tori Socha

Tori Socha
Palm Springs—Patients diagnosed with fibromyalgia experience widespread pain and other chronic conditions that often negatively affect function and lead to decreased health-related quality of life. A major therapeutic goal in the management...
Palm Springs—Patients diagnosed with fibromyalgia experience widespread pain and other chronic conditions that often negatively affect function and lead to decreased health-related quality of life. A major therapeutic goal in the management...
Palm Springs—Patients diagnosed...
03/16/2012
First Report Managed Care
Risk Factors for Developing Fibromyalgia
03/16/2012

Tori Socha

Tori Socha
Palm Springs—Fibromyalgia, a chronic condition characterized by chronic widespread pain, hyperalgesia, allodynia, and chronic fatigue, affects 3 million to 5 million people in the United States. Previous studies have linked fibromyalgia to...
Palm Springs—Fibromyalgia, a chronic condition characterized by chronic widespread pain, hyperalgesia, allodynia, and chronic fatigue, affects 3 million to 5 million people in the United States. Previous studies have linked fibromyalgia to...
Palm Springs—Fibromyalgia, a...
03/16/2012
First Report Managed Care
Type 2 Diabetes Treatment with Oral Antidiabetic Drugs
03/16/2012

Tim Casey

Tim Casey
New Orleans—With an increasing number of people with prediabetes and type 2 diabetes, healthcare professionals are spending countless hours and dollars trying to figure out ways to prevent and treat the disease. At the ASHP meeting, 2...
New Orleans—With an increasing number of people with prediabetes and type 2 diabetes, healthcare professionals are spending countless hours and dollars trying to figure out ways to prevent and treat the disease. At the ASHP meeting, 2...
New Orleans—With an increasing...
03/16/2012
First Report Managed Care
US Trends in Physician Referrals
03/16/2012

Tori Socha

Tori Socha
Patients who are referred to a specialist tend to incur greater healthcare spending compared with those who remain in primary care.
Patients who are referred to a specialist tend to incur greater healthcare spending compared with those who remain in primary care.
Patients who are referred to a...
03/16/2012
First Report Managed Care

Department

News Connection
TNF-α Antagonist Use in Autoimmune Diseases
03/16/2012

Eileen Koutnik-Fotopoulos

Eileen Koutnik-Fotopoulos
Tumor necrosis factor (TNF)-α antagonists have proven successful in the treatment of autoimmune diseases; however, there have been concerns about the safety of these biologic drugs. New research found that the overall initiation of TNF-α...
Tumor necrosis factor (TNF)-α antagonists have proven successful in the treatment of autoimmune diseases; however, there have been concerns about the safety of these biologic drugs. New research found that the overall initiation of TNF-α...
Tumor necrosis factor (TNF)-α...
03/16/2012
First Report Managed Care

Advertisement

Advertisement

Advertisement

FRMC Volume 21, Issue 2

Current Issue

June 2024
Volume 21
Issue 2
Current Issue
Issue Archive

Advertisement

Advertisement

What's Trending?

News
Report: Cancer Will Kill 13.2 Million a Year by 2030
06/02/2010
06/02/2010
First Report Managed Care
Literature Review: Opioid-Induced Constipation
03/16/2015
These studies focus on the causes, consequences, and management of opioid-induced constipation.
These studies focus on the causes, consequences, and management of opioid-induced constipation.
These studies focus on the...
03/16/2015
First Report Managed Care
News
New Standardized Insurance Forms Could Make Buying Easier
08/23/2011
08/23/2011
First Report Managed Care
News
FDA Approves Denosumab for New Indication
12/10/2014
The FDA approved denosumab for the treatment of hypercalcemia of malignancy refractory to bisphosphonate therapy.
The FDA approved denosumab for the treatment of hypercalcemia of malignancy refractory to bisphosphonate therapy.
The FDA approved denosumab for...
12/10/2014
First Report Managed Care
News
CMS Announces Voluntary Bundled Payment Model
01/10/2018
The CMS recently announced the launch of a new voluntary bundled payment model that will cover multiple specialties and care services.
The CMS recently announced the launch of a new voluntary bundled payment model that will cover multiple specialties and care services.
The CMS recently announced the...
01/10/2018
First Report Managed Care

Video Insights

Hayward
Videos
Evolving Health Care Contact Centers Into Drivers of Value-Based Care
07/31/2024
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact...
07/31/2024
First Report Managed Care
Lucille Accetta Headshot
Videos
Enhancing Patient Medication Adherence: Insights and Strategies From Asembia 2024
06/11/2024
Lucille Accetta, PharmD, MBA, MSPH, Senior Vice President of CVS Specialty Operations
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health...
06/11/2024
First Report Managed Care
Melissa Andel, Principal, CommonHealth Solutions, LLC
Videos
Navigating the Impact of the Inflation Reduction Act: Implications for Payers, Patients, and Manufacturers
05/24/2024
Melissa Andel, Principal, CommonHealth Solutions, LLC
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the...
05/24/2024
First Report Managed Care
Joe DePinto Headshot
Videos
Navigating Payment Models in the CGT Landscape: Insights and Innovations
05/21/2024
Joe DePinto, Head of Cell, Gene, and Advanced Therapies, McKesson
An expert discusses the evolution and challenges of payment models in the cell and gene therapy (CGT) space reviewed during his session at Asembia 2024.
An expert discusses the evolution and challenges of payment models in the cell and gene therapy (CGT) space reviewed during his session at Asembia 2024.
An expert discusses the...
05/21/2024
First Report Managed Care
Jennifer L. Mathieu Senior Vice President, Professional and Government Affairs at AMCP
Videos
Unlocking the Future of Managed Care Pharmacy: A Deep Dive into Federal Legislation and Regulations
05/15/2024
Jennifer L. Mathieu Senior Vice President, Professional and Government Affairs, AMCP
Learn about developments in federal legislation and regulations within the pharmacy landscape shaping the future of managed care in an interview with a session presenter from AMCP 2024.
Learn about developments in federal legislation and regulations within the pharmacy landscape shaping the future of managed care in an interview with a session presenter from AMCP 2024.
Learn about developments in...
05/15/2024
First Report Managed Care
Tejaswi Kompala
Videos
Personalizing Weight Loss Management With GLP-1 Agonists
04/05/2024

Featuring Tejaswi Kompala, MD, head of cardiometabolic clinical strategy, Teladoc 

Featuring Tejaswi Kompala, MD, head o...
Delve into the rising demand for anti-obesity medications, the complexities of obesity management, and the importance of personalized approaches in improving cardiometabolic health in this insightful interview.
Delve into the rising demand for anti-obesity medications, the complexities of obesity management, and the importance of personalized approaches in improving cardiometabolic health in this insightful interview.
Delve into the rising demand for...
04/05/2024
First Report Managed Care
Zaubler Headshot
Videos
Integrating Behavioral Health Services to Reduce ED Visits: Substance Use Disorder and Social Determinants of Health
03/27/2024

Featuring Tom Zaubler, MD, MPH, CMO at NeuroFlow

Featuring Tom Zaubler, MD, MPH, CMO a...
Join us for the continuation of an engaging two-part series showcasing an expert dedicated to reducing emergency department visits through the integration of behavioral health practices. Dr Zaubler will share invaluable insights into...
Join us for the continuation of an engaging two-part series showcasing an expert dedicated to reducing emergency department visits through the integration of behavioral health practices. Dr Zaubler will share invaluable insights into...
Join us for the continuation of...
03/27/2024
First Report Managed Care
Zaubler Headshot
Videos
Integrating Behavioral Health Services to Reduce ED Visits: Suicide Prevention and Preemptive Primary Care
03/25/2024

Featuring Tom Zaubler, MD, MPH, CMO at NeuroFlow

Featuring Tom Zaubler, MD, MPH, CMO a...
Come join us for the first installment of a captivating two-part series featuring an expert committed to minimizing emergency department visits through the implementation of behavioral health integrations. Dr Zaubler will offer valuable...
Come join us for the first installment of a captivating two-part series featuring an expert committed to minimizing emergency department visits through the implementation of behavioral health integrations. Dr Zaubler will offer valuable...
Come join us for the first...
03/25/2024
First Report Managed Care
Yash Prajapati
Videos
Navigating the Evolution of Digital Solutions in Health Care
02/27/2024

Featuring Yash Prajapati, consultant at ZS Associates 

Featuring Yash Prajapati, consultant ...
Join us in exploring the challenges and opportunities in the development, approval, and integration of digital therapeutic solutions with ZS Associates consultant Yash Prajapati.
Join us in exploring the challenges and opportunities in the development, approval, and integration of digital therapeutic solutions with ZS Associates consultant Yash Prajapati.
Join us in exploring the...
02/27/2024
First Report Managed Care
Mansur Shomali
Videos
Advancements and Challenges in Diabetes Management
02/27/2024

Featuring Mansur Shomali, MD, chief medical officer at Welldoc, endocrinologist at MedStar Health 

Featuring Mansur Shomali, MD, chief m...
Learn about the state of digital therapeutics for disease management such as diabetes care in terms of cost, outcomes, integration, and more with Dr Mansur Shomali, CMO at Welldoc.
Learn about the state of digital therapeutics for disease management such as diabetes care in terms of cost, outcomes, integration, and more with Dr Mansur Shomali, CMO at Welldoc.
Learn about the state of digital...
02/27/2024
First Report Managed Care

Subscribe to our eNewsletters!

First Report Managed Care Newsletter

March 2012 Volume 9 Issue 3

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement